BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27046697)

  • 1. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
    Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
    Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
    Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
    Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
    Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
    J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Eriksson H; Lyth J; Andersson TM
    Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
    Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
    Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
    Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
    Utjés D; Lyth J; Lapins J; Eriksson H
    Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.
    Lyth J
    Melanoma Res; 2018 Dec; 28(6):637-640. PubMed ID: 29994850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients.
    Lyth J; Mikiver R; Nielsen K; Ingvar C; Olofsson Bagge R; Isaksson K
    Eur J Surg Oncol; 2023 Oct; 49(10):106974. PubMed ID: 37423872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
    Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
    Int J Cancer; 1999 Mar; 80(5):646-51. PubMed ID: 10048960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
    Lyth J; Carstensen J; Synnerstad I; Lindholm C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.